Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Microglia in ALS: the good, the bad, and the resting.

Henkel JS, Beers DR, Zhao W, Appel SH.

J Neuroimmune Pharmacol. 2009 Dec;4(4):389-98. doi: 10.1007/s11481-009-9171-5. Review.

PMID:
19731042
2.

Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis.

Sargsyan SA, Monk PN, Shaw PJ.

Glia. 2005 Sep;51(4):241-53. Review.

PMID:
15846792
3.

Innate immunity in amyotrophic lateral sclerosis.

Moisse K, Strong MJ.

Biochim Biophys Acta. 2006 Nov-Dec;1762(11-12):1083-93. Epub 2006 Mar 31. Review.

4.

The microglial-motoneuron dialogue in ALS.

Appel SH, Zhao W, Beers DR, Henkel JS.

Acta Myol. 2011 Jun;30(1):4-8. Review.

5.

[ALS and microglia--a player for non-cell-autonomous neuron death].

Yamanaka K, Yamashita H.

Brain Nerve. 2007 Oct;59(10):1163-70. Review. Japanese.

PMID:
17969357
7.
8.

Serotonergic mechanisms in amyotrophic lateral sclerosis.

Sandyk R.

Int J Neurosci. 2006 Jul;116(7):775-826. Review.

PMID:
16861147
9.

T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?

Appel SH, Beers DR, Henkel JS.

Trends Immunol. 2010 Jan;31(1):7-17. doi: 10.1016/j.it.2009.09.003. Epub 2009 Oct 31. Review.

10.

Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.

Tu PH, Gurney ME, Julien JP, Lee VM, Trojanowski JQ.

Lab Invest. 1997 Apr;76(4):441-56. Review. Erratum in: Lab Invest 1997 Jun;76(6):followi.

PMID:
9111507
11.

Mechanism and treatment of motoneuron degeneration in ALS: what have SOD1 mutants told us?

Xu Z.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Sep;1(4):225-34. Review.

PMID:
11465016
12.

Microglia in amyotrophic lateral sclerosis.

Dewil M, Van Den Bosch L, Robberecht W.

Acta Neurol Belg. 2007 Sep;107(3):63-70. Review.

PMID:
18072333
13.

[Proximal axonal injuries as experimental models for adult motoneuron degeneration].

Watabe K.

Brain Nerve. 2007 Oct;59(10):1179-86. Review. Japanese.

PMID:
17969359
14.

Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.

Turner BJ, Talbot K.

Prog Neurobiol. 2008 May;85(1):94-134. doi: 10.1016/j.pneurobio.2008.01.001. Epub 2008 Jan 16. Review.

PMID:
18282652
15.

Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosis.

Weydt P, Möller T.

Neuroreport. 2005 Apr 25;16(6):527-31. Review.

PMID:
15812300
16.

[Implications of successful immunotherapy in ALS model mice].

Urushitani M.

Brain Nerve. 2008 Jun;60(6):643-51. Review. Japanese.

PMID:
18567360
17.

[The causes and mechanism of selective motor neuron death in amyotrophic lateral sclerosis].

Van den Bosch L.

Verh K Acad Geneeskd Belg. 2006;68(4):249-69. Review. Dutch.

PMID:
17214440
18.

Early abnormalities in transgenic mouse models of amyotrophic lateral sclerosis.

Durand J, Amendola J, Bories C, Lamotte d'Incamps B.

J Physiol Paris. 2006 Mar-May;99(2-3):211-20. Epub 2006 Jan 30. Review.

PMID:
16448809
19.

Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis.

Hooten KG, Beers DR, Zhao W, Appel SH.

Neurotherapeutics. 2015 Apr;12(2):364-75. doi: 10.1007/s13311-014-0329-3. Review.

20.

Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis.

Zhao W, Beers DR, Appel SH.

J Neuroimmune Pharmacol. 2013 Sep;8(4):888-99. doi: 10.1007/s11481-013-9489-x. Epub 2013 Jul 25. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk